Abstract
There is currently a high incidence of multidrug-resistant bacteria (MDRs) in hospital environments, a global alert situation. Among the critical priority bacteria listed by the WHO (World Health Organization) in 2024, Pseudomonas aeruginosa is in the second group, of high priority, for the development of new treatments. Among the treatment alternatives, phytotherapy has shown promising a…